Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Baxter International    BAX

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Baxter International : Correction to Puerto Rico Saline Shipments Story

share with twitter share with LinkedIn share with facebook
share via e-mail
0
09/27/2017 | 11:42pm CEST

Bristol-Myers Squibb Co. said its plant in Humacao appeared to suffer some damage during the hurricane, but a second plant, in Manati, wasn't harmed. "Baxter Says Saline Shipments Disrupted in Hurricane-Wracked Puerto Rico," published at 5:03 p.m. ET, incorrectly stated the second plant was in Guaynabo in the 12th paragraph.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BAXTER INTERNATIONAL
03:15pBAXTER INTERNATIONAL INC : quaterly earnings release
10/19 BAXTER INTERNATIONAL : Trademark Application for "HDX" Filed by Baxter Internati..
10/19 BAXTER INTERNATIONAL : Honors Recipients of Ninth Annual Young Investigator Awar..
10/17 BAXTER INTERNATIONAL : to Present at Credit Suisse 26th Annual Healthcare Confer..
10/16 BAXTER INTERNATIONAL : to Present at the Credit Suisse 26th Annual Healthcare Co..
10/16 BAXTER INTERNATIONAL : Provides Update on Puerto Rico Recovery Status Post Hurri..
10/13 DELIVERING ON OUR MISSION : Recovery Efforts in Puerto Rico
10/12 BAXTER INTERNATIONAL : Provides Update on Puerto Rico Recovery Status Post Hurri..
10/12 BAXTER INTERNATIONAL : Enrolls First Patients in U.S. and Colombia Clinical Tria..
10/10 BAXTER INTERNATIONAL : Initiates Voluntary Nationwide Recall of One Shipment of ..
More news
News from SeekingAlpha
10/13 FDA assisting Baxter with restart of Puerto Rico minibag production
10/11 DENTSPLY : An Example Of Misaligned Incentives Leading To A Bad Outcome
10/09 First meeting of new FDA advisory committee this week
10/04 Edwards Lifesciences Is A Buy - Cramer's Lightning Round (10/3/17)
10/03 Has Medtronic's Decline Made It A Buy?
Financials ($)
Sales 2017 10 492 M
EBIT 2017 1 669 M
Net income 2017 1 144 M
Finance 2017 655 M
Yield 2017 0,92%
P/E ratio 2017 33,06
P/E ratio 2018 26,35
EV / Sales 2017 3,23x
EV / Sales 2018 3,04x
Capitalization 34 583 M
Chart BAXTER INTERNATIONAL
Duration : Period :
Baxter International Technical Analysis Chart | BAX | US0718131099 | 4-Traders
Technical analysis trends BAXTER INTERNATIONAL
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 17
Average target price 67,2 $
Spread / Average Target 5,9%
EPS Revisions
Managers
NameTitle
José E. Almeida Chairman, President & Chief Executive Officer
Scott Pleau Vice President-Operations
Catherine R. Smith Chief Financial Officer, Director & Executive VP
Paul E. Martin Chief Information Officer & Vice President
Marcus Schabacker Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
BAXTER INTERNATIONAL43.98%34 785
MEDTRONIC PLC10.18%106 457
ZIMMER BIOMET HOLDINGS INC16.95%24 403
C R BARD INC45.55%23 764
HOYA CORPORATION29.67%21 882
TERUMO CORP8.32%15 770